Effectiveness of Granulocyte-Macrophage Colony-Stimulating Factor Therapy in Autoimmune Pulmonary Alveolar Proteinosis

GM-CSF represents a useful approach in the treatment of aPAP. The optimal indication, dose and duration of therapy, and the factors predicting response and relapse need to be defined by future studies.